Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Buyback of Class B shares in Essity during week 45, 2024

Between November 4, 2024, and November 8, 2024, Essity Aktiebolag (publ) repurchased a total of 270,000 own Class B shares (ISIN: SE0009922164) under the framework of the buyback program as resolved by the Board of Directors.The share purchase is part of the SEK 3bn buyback program announced by Essity on June 17, 2024. The buyback program will extend from June 17, 2024, until the 2025 Annual General Meeting and be implemented in accordance with the EU Market Abuse Regulation (MAR) and the European Commission’s Delegated Regulation 2016/1052 (Safe Harbour Regulation). The share repurchase

Notification of managers’ and closely related parties’ transactions with Dampskibsselskabet NORDEN A/S’ shares in connection with share buy-back program

ANNOUNCEMENT NO. 243 – 11 NOVEMBER 2024   In connection with the announced share buy-back program in NORDEN, A/S Motortramp continuously sells shares pro rata and the market is to be informed accordingly – see the attached file and announcements nos. 235/24 and 237/24.   Kind regards, Dampskibsselskabet NORDEN A/S   Martin Badsted CFO     For further information: Therese Möllevinge, Head of Investor Relations, tel.: +45 41 37 16 38, e-mail: thm@norden.com Isabella Zaugg Hansen, Investor Relations Manager, tel.: +45 27 62 90 96, e-mail: izh@norden.com

Abarceo Pharma will present at the BioStock Life Science Summit, November 21

The seventh edition of the BioStock Life Science Summit will take place in Lund on November 20-21. Chair Adam Bruce will present Abarceo Pharma to industry leaders, specialist investors and potential partners.The Summit connects innovation and capital, providing small-to-medium size Nordic companies from a wide range of therapeutic areas the platform and opportunity to make their case to both Swedish and international investors as well as top-level potential partners in a unique boutique setting.    Date: November 21  Time: 14:10 Location: Auditorium at Medicon Village, Lund

Curasight will present at the BioStock Life Science Summit, November 21

The seventh edition of the BioStock Life Science Summit will take place in Lund on November 20-21. CSO Andreas Kjaer will present Curasight to industry leaders, specialist investors and potential partners.The Summit connects innovation and capital, providing small-to-medium size Nordic companies from a wide range of therapeutic areas the platform and opportunity to make their case to both Swedish and international investors as well as top-level potential partners in a unique boutique setting.    Date: November 21 Time: 14:05 Location: Auditorium at Medicon Village, Lund Read

Presenting INGA: the next generation of sustainable plastics made from CO₂ emissions

FORTUM CORPORATION PRESS RELEASE 11 November 2024, 12.00 EET Fortum Recycling & Waste, a leading company in circular solutions and waste management, proudly presents INGA: the world’s first biodegradable plastic born entirely from CO₂. INGA captures the value of CO₂ emissions to create raw materials that can revolutionise plastic production – fossil-free and without microplastics. “It is time to rethink plastic production and move away from fossil feedstock. There is an ever-increasing need for high-quality sustainable plastics that can be used everywhere and that meet the set

Announcement of a Change in Shareholding According to Chapter 9, Section 10 of the Finnish Securities Market Act

Sitowise Group Plc Stock Exchange Release 11 November 2024 at 12.00 p.m. (EET) Sitowise Group Plc (the "Company") has on 8 November 2024 received a notification in accordance with the Chapter 9, Section 10 of the Finnish Securities Market Act from Morgan Stanley, according to which Morgan Stanley & Co International Plc's holding of the shares and votes of the Company has decreased below 5.00 percent on 7 November 2024. According to the notification, Morgan Stanley holds indirectly a total of 46,304 shares corresponding to 0.13 percent of the Company’s shares and votes, and a total of

Dampskibsselskabet NORDEN A/S – weekly report on share buy-back

ANNOUNCEMENT NO. 242 – 11 NOVEMBER 2024   On 1 November 2024, NORDEN initiated a share buy-back programme in accordance with Regulation No. 596/2014 of the European Parliament and Council of 16 April 2014 (MAR) and Commission Delegated Regulation (EU) 2016/1052, (Safe Harbour regulation). The share buy-back programme runs from 1 November 2024 up to and including no later than 22 January 2025. For details, please see announcement no. 235 of 31 October 2024.   Under the share buy-back programme, NORDEN will purchase shares for up to a total of USD 12 million (approximately DKK 83

Form 8.3 - Centamin Plc

FORM 8.3   PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”)   1. KEY INFORMATION   +--------------------------------------------------+---------------------------+|(a) Full name of discloser: |Ninety One UK Ltd |+--------------------------------------------------+---------------------------+|(b) Owner or controller of interests and short |  ||positions disclosed, if different from

Buybacks of shares by H&M during week 45, 2024

Between 4 November 2024 and 8 November 2024 H & M Hennes & Mauritz AB (publ) (LEI code 529900O5RR7R39FRDM42) has repurchased in total 706,140 own B shares (ISIN: SE0000106270) as part of the share buyback programme initiated by the board of directors. The share buybacks form part of the SEK 1 billion share buyback programme that H&M announced on 26 September 2024. The share buyback programme, which runs between 26 September 2024 and no later than 26 November 2024, is being carried out in accordance with Regulation (EU) No 596/2014 on market abuse (the Market Abuse Regulation – MAR) and

The Future of Online Casinos: Virtual Reality and Beyond

The digital revolution has significantly transformed various industries in the past few decades, and the world of online casinos is no exception. Today, the industry stands on the brink of a new era powered by virtual reality (VR) advancements and emerging technologies that promise to reshape the gambling landscape. Our experts explore how virtual reality, alongside other future technologies, has the potential to influence the evolution of the best online casinos .The Evolution of Online Casinos The earliest versions of online casinos were

Correction to the WPTG Q3 Earnings Release

In the WPTG Q3 2024 earnings release published on November 11, 2024, at 08:00 CET, the Q3 2024 financial report was not included as an attachment.The Q3 2024 financial report is now attached to this correction. For the complete Q3 2024 financial report, please refer to the attached document. Contact: IR Manager ir@whitepearltech.com +46 707 340 804 Marco Marangoni CEO marco.marangoni@whitepearltech.com +598 93 370 044 Certified Adviser: Amudova AB info@amudova.se +46 8 546 017 58 About WPTG White Pearl Technology Group AB, listed on Nasdaq First North Growth

Method for Scalp Cooling Now Offered to More Patients – Reduces Hair Loss in Cancer Patients

The Aleris Oncology Clinic at Sabbatsberg Hospital, Stockholm - Sweden is expanding access to an innovative scalp cooling treatment for cancer patients after a successful pilot project in collaboration with Dignitana.   “We have observed improvements in our patients’ psychosocial well-being,” says Anna-Maria Hasselgren Häll, oncology nurse at Aleris Christinakliniken.   Aleris has conducted a series of extensive trials on an innovative scalp cooling treatment that reduces hair loss in cancer patients undergoing chemotherapy for solid tumors. Patients beginning chemotherapy will

Hexagon expands its Hexagon Agility FleetCare business - acquires Specialty Fleet Services

11 November 2024: Hexagon Agility, a subsidiary of Hexagon Composites, announced the acquisition of the assets of Specialty Fleet Services, a leading natural gas (CNG,LNG and RNG) mobile service and inspection provider in the United States and Canada. Specialty Fleet Services, based in California, provides comprehensive maintenance solutions for fleets to minimize truck downtime. With this acquisition, Hexagon Agility FleetCare expands its nationwide after-sales support network to serve customers more effectively while tripling its mobile service capabilities. The business will be fully

Camurus to present at Jefferies London Healthcare Conference

Lund, Sweden — 11 November 2024 — Camurus (NASDAQ STO: CAMX) announces that Fredrik Tiberg, President and CEO, is presenting at the Jefferies Healthcare Conference in London on 20 November at 1.30 pm local time (GMT), giving an update on the company’s recent development and progress. A webcast of the presentation can be accessed via:https://wsw.com/webcast/jeff315/camx.st/2236248 For more informationFredrik Joabsson, Chief Business Development OfficerTel. +46 (0)70 776 17 37ir@camurus.com (mir@camurus.com) About CamurusCamurus is a Swedish, science-led biopharmaceutical

Amferia wins Red Dot Award for Innovative Design addressing bacterial infections and antibiotic resistance

Swedish medtech company Amferia has been awarded the Red Dot Award for its elevator pitch logotype in the Brand & Communication Design category. The new logo describes the company’s innovation and purpose in three words: Amferia kills bacteria.”The award highlights our commitment to addressing bacterial infections and antibiotic resistance. Amferia’s innovation contributes to the solution, but we also have to communicate that in an innovative way to reach a global audience.” says Anand Rajasekharan, CEO and co-founder of Amferia.   The Red Dot Award, established in 1955,

A question of demand – hydrogen and renewable electricity for the EU steel and iron transition

The steel industry is responsible for around 5% of CO2 emissions in the EU and the sector needs to cut carbon emissions by 55% by 2030 to align with climate targets. A new report based on an analysis of announced green steel projects, which would account for one third of current EU steel production, shows that green steel could need 19% of the total EU policy target for domestic renewable hydrogen production. The report also shows that:   · The 19% of the total EU policy target for domestic renewable hydrogen production needed for green steel is equal to 1.7 million tonnes

Medivir’s CEO: “There is an obvious need for fostrox”

Medivir has gone through an eventful period, marked by the presentation of clinical results at ESMO and a new collaboration agreement with pharmaceutical giant Eisai. The next target is a randomized phase IIb study to enable breakthrough therapy designation and accelerated approval process. CEO Jens Lindberg notes that these recent developments have strengthened fostrox’s potential to become the first approved treatment for second-line liver cancer.Read the article at biostock.se: https://www.biostock.se/en/2024/11/medivirs-ceo-there-is-an-obvious-need-for-fostrox/ This is a press

Telia announces tender offer and proposal in respect of certain outstanding GBP notes

Not for distribution, directly or indirectly, in or into or to any person located or resident in the United States, its territories and possessions (including Puerto Rico, the U.S. Virgin Islands, Guam, American Samoa, Wake Island and the Northern Mariana Islands), any state of the United States or the District of Columbia or to any U.S. Person (as defined in Regulation S under the U.S. Securities Act of 1933, as amended) or in or into any other jurisdiction where it is unlawful to distribute this announcement. Telia Company AB (“Telia”) has today announced separate invitations to: (i)

A Festive Journey of Flavours: Experience Finnish Christmas in Helsinki

Photo: Jussi Hellsten, Torikorttelit This winter, Helsinki invites you to indulge in the tastes, traditions and treats of a Finnish Christmas. During the month leading up to the holidays, the city transforms into a winter wonderland where markets, festive events and Christmas lunches celebrate the Finnish capital’s vibrant food culture. As December approaches, Christmas magic finds itself into Helsinki’s restaurants, delis and market squares. It’s the cozy season and Finns know how to make the most of it, lighting up dark evenings with twinkling lights, gathering for long,

Immedica welcomes Benjamin Owens as Head of Corporate Development

Stockholm, November 11, 2024 – Immedica is pleased to announce that Benjamin Owens, Ph.D. has joined the company as Executive Vice President and Head of Corporate Development. Ben brings 15 years of experience in the life sciences field including roles in business development and operational leadership across both R&D- and commercial-stage companies. Benjamin has a track record of successfully sourcing, leading and executing strategic transactions, including M&A, cross-border licensing, financing and company formation. With broad expertise in areas ranging from R&D,  clinical development

Repurchase of Truecaller B shares in week 45, 2024

During 4 November 2024 and 8 November 2024 Truecaller AB (publ) (LEI code 549300TEYF1FA5G5GK26) has repurchased in total 50,000 own B shares (ISIN: SE0016787071), corresponding to 0.01% of outstanding capital, as part of the share buyback programme initiated by the board of directors. Since the start of the programme, in the end of May, almost 3.7 million B-shares has been repurchased which corresponds to 1.04% of the outstanding capital.The share buybacks form part of the share buyback programme announced by Truecaller on 28 May 2024. The share buyback programme will run between 28 May up

Qlife announces outcome in directed issues

NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO, THE UNITED STATES OF AMERICA, CANADA, AUSTRALIA, NEW ZEALAND, JAPAN, HONG KONG, SOUTH KOREA, SINGAPORE, SOUTH AFRICA, SWITZERLAND, RUSSIA OR BELARUS OR ANY OTHER STATE OR JURISDICTION IN WHICH THE RELEASE, DISTRIBUTION OR PUBLICATION WOULD BE UNLAWFUL OR REQUIRE REGISTRATION OR ANY OTHER MEASURE. Qlife Holding AB (publ) (”Qlife” or the ”Company”) announces the outcome of the directed issues of shares and warrants to Warthoe Af 1967 ApS (owned by Thomas Warthoe, CEO), Altia Invest ApS (

Smoltek Hydrogen participates in the Scandinavian delegation for meetings with the German hydrogen industry

This press release is an English version of the previously published Swedish version, which has interpretive precedence. Smoltek (“Smoltek” or “the Company”) announces that the subsidiary Smoltek Hydrogen has been invited to participate in a Scandinavian delegation of technology leading hydrogen companies for a round-trip to Germany’s energy-producing regions in Rhur and central Germany. This is an excellent opportunity to network with the German hydrogen industry and talk about Smoltek Hydrogen's low iridium porous transport electrode (PTE) for PEM electrolyzers.Between 11 and 13

The exercise period for CLS warrants of series TO 7 begins today

In June 2024, Clinical Laserthermia Systems AB (publ) (“CLS” or the “Company”) carried out a rights issue of shares and warrants of series TO 7 B (the “Rights Issue”). The exercise period for the warrants begins today, November 11, 2024 and runs up to and including November 22, 2024. One (1) warrant entitle the holder to subscribe for one (1) new B-share in CLS. The subscription price per B-share that is subscribed for through exercising the warrants has, in accordance with the terms and conditions for the warrants, been set to SEK 3.68. If all warrants are exercised, CLS will receive

There are no items matching the current filter
There are no more items matching the current filter
Back to top